0001729149-26-000029
SEC filingRevenue grew 27.5% to $75.4M, driven by organic expansion and the Lehan acquisition, while net income was flat at $2.6M due to the absence of prior-year ventilator buyback gains.
Gross profit rose 28.7% to $42.8 million, with gross margin improving to 56.8% from 56.3% in the prior year. Management attributed the margin improvement to disciplined cost management and favorable operating leverage in the rental revenue base. Operating income increased 11.8% to $4.3 million, with operating margin of 5.7%, as higher revenue and gross profit offset increases in selling, general, and administrative expenses.
Management expects to continue growing through expansion of existing service areas and cost-efficient entry into new territories. The broader trend toward home-based care and an aging population support demand for the company's services. The company has not experienced material adverse impacts from tariffs to date but continues to monitor trade policy developments. The Lehan acquisition positions Viemed in the maternal health market, and the company expects to realize operational synergies from the integration.